文献速递淋巴瘤

甲状腺MALT淋巴瘤:自我损害以获取潜在T细胞辅助

Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
PubMed 文献 · Leukemia · 2021-05-21

本研究对131例MALT淋巴瘤(含76例甲状腺原发)进行93基因靶向测序,发现甲状腺MALT淋巴瘤中TET2、CD274、TNFRSF14和TNFAIP3频繁存在有害突变。CD274/TNFRSF14失活可能解除对T细胞的抑制,促进T细胞辅助恶性B细胞,且与桥本甲状腺炎及血沉升高相关。

要点

  • 甲状腺MALT淋巴瘤高频携带TET2、CD274、TNFRSF14和TNFAIP3有害突变。
  • CD274/TNFRSF14遗传学异常与活化T细胞比例及转化母细胞水平升高显著相关。
  • CD274及TNFRSF14遗传学改变均与桥本甲状腺炎显著相关。

核心结论

  • 甲状腺MALT淋巴瘤B细胞中CD274/TNFRSF14失活可能失调其与T细胞的相互作用,促进共刺激并损害外周耐受。

研究设计与样本

  • 对131例MALT淋巴瘤(其中76例来自甲状腺)进行93个基因的靶向测序。

主要发现

  • 甲状腺MALT淋巴瘤中TET2突变频率86%,CD274突变频率53%,TNFRSF14突变频率53%,TNFAIP3突变频率30%。
  • CD274缺失频繁,与突变合并见于68%的病例。
  • CD274突变/缺失与TNFRSF14突变显著相关(p = 0.001)。
  • CD274/TNFRSF14遗传学异常病例中,恶性B细胞附近活化T细胞(CD4+CD69+/CD4+)比例及转化母细胞水平均显著高于无这些改变者。
  • CD274和TNFRSF14遗传学改变均与桥本甲状腺炎显著相关(分别为p = 0.01和p = 0.04),CD274突变/缺失还与红细胞沉降率升高相关(p = 0.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The development of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is driven by chronic inflammatory responses and acquired genetic changes. To investigate its genetic bases, we performed targeted sequencing of 93 genes in 131 MALT lymphomas including 76 from the thyroid. We found frequent deleterious mutations of TET2 (86%), CD274 (53%), TNFRSF14 (53%), and TNFAIP3 (30%) in thyroid MALT lymphoma. CD274 was also frequently deleted, together with mutation seen in 68% of cases. There was a significant association between CD274 mutation/deletion and TNFRSF14 mutation (p = 0.001). CD274 (PD-L1) and TNFRSF14 are ligands for the co-inhibitory receptor PD1 and BTLA on T-helper cells, respectively, their inactivation may free T-cell activities, promoting their help to malignant B-cells. In support of this, both the proportion of activated T-cells (CD4+CD69+/CD4+) within the proximity of malignant B-cells, and the level of transformed blasts were significantly higher in cases with CD274/TNFRSF14 genetic abnormalities than those without these changes. Both CD274 and TNFRSF14 genetic changes were significantly associated with Hashimoto's thyroiditis (p = 0.01, p = 0.04, respectively), and CD274 mutation/deletion additionally associated with increased erythrocyte sedimentation rate (p = 0.0001). In conclusion, CD274/TNFRSF14 inactivation in thyroid MALT lymphoma B-cells may deregulate their interaction with T-cells, promoting co-stimulations and impairing peripheral tolerance.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Wu F, Watanabe N, Tzioni MM, et al. Thyroid MALT lymphoma: self-harm to gain potential T-cell help. Leukemia. 2021. PMID: 34021249. doi:10.1038/s41375-021-01289-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。